Science, Politics and the Pharmaceutical Industry: Controversy and Bias in Drug Regulation

Of the myriad of issues surrounding the testing and regulation of medicine, focuses on whether and how bias may influence the scientific processes of evaluating the safety and effectiveness of new drugs. Finds that corporate bias is indeed a significant social and political problem both in Britain and the US, often compromising the best interests of patients who take drugs that are either unsafe or ineffective or both. Demonstrates the scope and depth of bias from individuals to institutions and from animal testing to marketing claims. Annotation c. by Book News, Inc., Portland, Or.